64.20.Z - Activities of holding companies
69.20.Z - Accounting, bookkeeping and auditing activities; tax consultancy
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
70.22.Z - Business and other management consultancy activities
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
73.11.Z - Advertising agencies activities
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,3 | -0,3 | 1,4 | 514,8 |
EBITDA | -0,3 | -1,1 | -1,4 | -20,9 |
Short time liabilities | 2,9 | 3,2 | 1,7 | -48,2 |
Equity capital | 6,4 | 6 | 7,5 | 23,8 |
Operating profit (EBIT) | -0,6 | -1,5 | -1,7 | -16,1 |
Assets | 10 | 9,8 | 10,3 | 5,5 |
Net profit (loss) | 1,3 | -0,4 | 1,4 | 505,1 |
Cash | 0 | 0,2 | 0,4 | 132,6 |
Net income from sale | 3,6 | 4,7 | 5,7 | 19,8 |
Liabilities and provisions for liabilities | 3,6 | 3,7 | 2,8 | -24 |
Working assets | 2,7 | 2,3 | 3,4 | 47,2 |
Depreciation | 0,3 | 0,4 | 0,4 | 1,4 |
% | % | % | p.p. | |
Profitability of capital | 19,8 | -5,9 | 19,2 | 25,1 |
Equity capital to total assets | 63,8 | 61,8 | 72,5 | 10,7 |
Gross profit margin | 34,5 | -7,3 | 25,4 | 32,7 |
EBITDA Margin | -9,3 | -23,8 | -24 | -0,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 287 | 250 | 108 | -142 |
Current financial liquidity indicator | 0.9555112719535828 | 0.7158416509628296 | 1.7334721088409424 | 1 |
Net dept to EBITDA | -9.004904747009277 | -2.8075673580169678 | -1.4071930646896362 | 1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane